GlassScriptPhysician profile
Jennifer Lichon
NPI 1588047203
$3,556.01
in general payments reported to CMS, 2019-2025
41 companies · $1,041 in 2025
The $1,041 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $476 · 2021: $285 · 2022: $527 · 2023: $566 · 2024: $416 · 2025: $1,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,022.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $568.00 | 2019-2025 | |
| Intuitive Surgical, INC. | $390.68 | 2025 | |
| Pfizer INC. | $279.55 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $235.35 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $224.40 | 2019-2025 | Veozah |
| Baxter Healthcare | $186.05 | 2024-2025 | Seprafilm, Adept, Tisseel |
| Hologic Sales and Service, LLC | $151.16 | 2020-2024 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
| Smith+Nephew, INC. | $143.69 | 2025 | Pico, Renasys Touch |
| Mayne Pharma Commercial LLC | $108.46 | 2021-2023 | |
| Aspira Women'S Health INC | $99.33 | 2019-2020 | |
| Myovant Sciences INC. | $89.85 | 2021-2022 | |
| Organon LLC | $69.79 | 2023-2025 | Nexplanon, Jada System |
| Evofem Biosciences, INC. | $67.43 | 2021-2022 | |
| Channel Medsystems, INC. | $58.63 | 2023-2024 | |
| Coopersurgical, INC. | $58.07 | 2021-2024 | Paragard T 380a |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $56.98 | 2021-2023 | Slynd |
| Avion Pharmaceuticals | $53.31 | 2019-2023 | Balcoltra |
| Axonics, INC. | $52.79 | 2021-2023 | Axonics |
| Therapeuticsmd, INC. | $50.30 | 2020 | |
| Scynexis, INC. | $49.66 | 2022 | |
| Daiichi Sankyo INC. | $48.20 | 2020-2022 | |
| Cepheid | $43.45 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.39 | 2020-2023 | |
| Millicent US INC | $43.10 | 2020-2024 | Intrarosa |
| Gynesonics, INC. | $42.02 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exact Sciences Corporation | $42.01 | 2023 | Cologuard Collection Kit |
| Meditrina | $34.15 | 2023-2025 | |
| Pacira Pharmaceuticals Incorporated | $32.47 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $29.29 | 2020 | |
| Laborie Medical Technologies Corp. | $24.39 | 2023 | |
| Ethicon US, LLC | $22.87 | 2022 | |
| Biogen, INC. | $22.56 | 2025 | Zurzuvae |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.40 | 2024 | Jardiance |
| Amag Pharmaceuticals, INC. | $16.85 | 2020 | |
| Ascend Therapeutics US, LLC | $15.64 | 2024 | |
| Roche Diagnostics Corporation | $15.42 | 2019 | |
| Coloplast Corp | $15.42 | 2022 | |
| Merck Sharp & Dohme LLC | $14.27 | 2021 | |
| Shield Therapeutics INC | $14.16 | 2023 | Accrufer |
| Karl Storz Endoscopy-America | $13.39 | 2024 | |
| Lupin INC. | $11.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Lichon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.